Merck Offers $28M to Settle Fosamax ONJ Suits

Washington Drug Letter
A A
Merck Dec. 9 offered to pay out $27.7 million to settle nearly 1,200 personal injury lawsuits claiming its osteoporosis drug Fosamax caused jaw-bone deterioration known as osteonecrosis of the jaw (ONJ).

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00